SCN10A Gene

SCN10A Gene

Gene Overview

<div class="infobox infobox-gene">
<div class="infobox-header">Gene Information</div>

| Gene Symbol | SCN10A |
|---|---|
| Full Name | Sodium Voltage-Gated Channel Alpha Subunit 10 |
| Protein Name | Nav1.8 |
| Chromosomal Location | 3p21-p22 |
| NCBI Gene ID | [6336](https://www.ncbi.nlm.nih.gov/gene/6336) |
| OMIM ID | [613217](https://www.omim.org/entry/613217) |
| Ensembl ID | [ENSG00000185313](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000185313) |
| UniProt ID | [Q9Y5Y9](https://www.uniprot.org/uniprotkb/Q9Y5Y9/) |
| Associated Diseases | [Small Fiber Neuropathy](/diseases/small-fiber-neuropathy), [Brugada Syndrome](/diseases/brugada-syndrome), [Chronic Pain](/diseases/chronic-pain), [Peripheral Neuropathy](/diseases/peripheral-neuropathy) |
| Expression | Peripheral sensory neurons, cardiac conduction system, sympathetic neurons |

</div>

Overview

SCN10A encodes the Nav1.8 voltage-gated sodium channel, also known as NaV1.8 or SCN10A. This channel is a member of the Nav1 family of voltage-gated sodium channels (Na_v1.1–Na_v1.9) and is predominantly expressed in peripheral [sensory neurons](/cell-types/sensory-neurons), particularly those involved in pain signaling. Nav1.8 is crucial for the generation and propagation of action potentials in nociceptive (pain-sensing) neurons and plays a lesser but significant role in cardiac electrical conduction[@waxman2020].

SCN10A Gene

Gene Overview

<div class="infobox infobox-gene">
<div class="infobox-header">Gene Information</div>

| Gene Symbol | SCN10A |
|---|---|
| Full Name | Sodium Voltage-Gated Channel Alpha Subunit 10 |
| Protein Name | Nav1.8 |
| Chromosomal Location | 3p21-p22 |
| NCBI Gene ID | [6336](https://www.ncbi.nlm.nih.gov/gene/6336) |
| OMIM ID | [613217](https://www.omim.org/entry/613217) |
| Ensembl ID | [ENSG00000185313](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000185313) |
| UniProt ID | [Q9Y5Y9](https://www.uniprot.org/uniprotkb/Q9Y5Y9/) |
| Associated Diseases | [Small Fiber Neuropathy](/diseases/small-fiber-neuropathy), [Brugada Syndrome](/diseases/brugada-syndrome), [Chronic Pain](/diseases/chronic-pain), [Peripheral Neuropathy](/diseases/peripheral-neuropathy) |
| Expression | Peripheral sensory neurons, cardiac conduction system, sympathetic neurons |

</div>

Overview

SCN10A encodes the Nav1.8 voltage-gated sodium channel, also known as NaV1.8 or SCN10A. This channel is a member of the Nav1 family of voltage-gated sodium channels (Na_v1.1–Na_v1.9) and is predominantly expressed in peripheral [sensory neurons](/cell-types/sensory-neurons), particularly those involved in pain signaling. Nav1.8 is crucial for the generation and propagation of action potentials in nociceptive (pain-sensing) neurons and plays a lesser but significant role in cardiac electrical conduction[@waxman2020].

The channel's unique electrophysiological properties—including slow inactivation kinetics, tetrodotoxin resistance, and temperature-dependent activation—make it a critical player in pain transduction. SCN10A variants are associated with a spectrum of clinical conditions ranging from painful peripheral neuropathies to cardiac arrhythmias, making Nav1.8 an important therapeutic target for both pain management and cardiac disorders[@dibhaji2019].

Gene Structure and Organization

The human SCN10A gene spans approximately 31 kb on chromosome 3p21-p22 and encodes a large membrane protein. The gene structure reflects the complexity required for precise regulation of this ion channel.

Genomic Organization

| Feature | Details |
|---------|---------|
| Chromosome | 3p21-p22 |
| Genomic Span | ~31 kb |
| Exons | 26 coding exons |
| Transcript Length | ~7.5 kb |
| Protein Length | 2016 amino acids |
| Molecular Weight | ~220 kDa |

Transcript Variants

Multiple SCN10A splice variants have been identified:

Protein Structure and Function

Nav1.8 is a large transmembrane protein that forms a functional sodium channel complex. Like other voltage-gated sodium channels, Nav1.8 consists of four homologous domains (I–IV), each containing six transmembrane segments (S1–S6).

Key Structural Features

Unique Electrophysiological Properties

Nav1.8 exhibits several distinctive properties that differentiate it from other sodium channels[@cummins2007]:

| Property | Nav1.8 | Nav1.7 | Nav1.5 |
|----------|--------|--------|--------|
| Activation Threshold | High (~-30 mV) | Low (~-55 mV) | Moderate |
| Inactivation Rate | Slow | Fast | Moderate |
| Tetrodotoxin Sensitivity | TTX-R | TTX-S | TTX-R |
| Recovery from Inactivation | Slow | Fast | Moderate |
| Temperature Sensitivity | High | Moderate | Low |

Clinical Relevance of These Properties

Tissue Distribution and Cell-Type Specificity

Peripheral Nervous System

Nav1.8 is predominantly expressed in:

| Cell Type | Expression Level | Primary Function |
|-----------|-----------------|-------------------|
| Nociceptive C-fibers | High | Pain detection |
| Adelta-fiber neurons | High | Sharp pain, temperature |
| Thermoreceptors | Moderate | Temperature sensing |
| Sympathetic neurons | Low-Moderate | Autonomic regulation |
| Cardiac sensory neurons | Low | Cardiac nociception |

Cardiac Expression

While primarily a neuronal channel, Nav1.8 has minor expression in the cardiac conduction system[@herreragranados2016]:

• Sinoatrial Node: Modulates pacemaker activity
• Atrioventricular Node: Affects conduction velocity
• His-Purkinje System: Contributes to ventricular conduction

Central Nervous System

• Minimal Expression: Nav1.8 is largely absent from the CNS
• Spinal Cord: Low-level expression in dorsal horn neurons
• Brain: Negligible expression

Normal Physiological Functions

Pain Signal Transduction

Nav1.8 is central to peripheral pain signaling:

Mechanisms

Temperature Sensing

Nav1.8 displays remarkable temperature sensitivity:

• Heat Activation: Activates at temperatures >40°C
• Threshold Alignment: Matches heat pain threshold
• Thermosensation: Contributes to both acute and chronic thermal pain

Neuroimmune Interactions

Nav1.8 participates in neuroimmune cross-talk:

• Inflammatory Mediator Sensitization: Upregulated by prostaglandins, ATP
• Macrophage/Schwann Cell Expression: Expression in non-neuronal cells during injury
• Trophic Factor Regulation: Modulated by NGF and other growth factors

Disease Associations

Small Fiber Neuropathy (SFN)

SCN10A mutations are a common cause of inherited [small fiber neuropathy](/diseases/small-fiber-neuropathy)[@faber2019]:

Clinical Features

• Pain Phenotype: Burning, stabbing, or electric shock-like pain
• Allodynia: Pain from normally non-painful stimuli
• Hypoalgesia: Reduced pain sensation in some variants
• Autonomic Symptoms: Sweating abnormalities, orthostatic intolerance

Genetic Mechanisms

| Mutation Type | Effect | Phenotype |
|--------------|--------|-----------|
| Gain-of-Function | Increased channel activity | Pain amplification |
| Loss-of-Function | Reduced channel activity | Reduced pain (Congenital insensitivity) |
| Missense | Altered properties | Variable |

Pathophysiology

Cardiac Arrhythmias

SCN10A variants are associated with several cardiac conditions[@behrends2021]:

Brugada Syndrome

• Prevalence: ~20% of Brugada syndrome cases have SCN10A variants
• Mechanism: Reduced cardiac sodium current (I_Na)
• Interaction: Often co-occurs with SCN5A (Nav1.5) variants

Cardiac Conduction Disease

• AV Block: Increased risk of heart block
• Bundle Branch Block: Delayed ventricular conduction
• Sudden Cardiac Death: Risk in severe cases

Atrial Fibrillation

• GWAS Associations: Multiple SCN10A variants linked to AF risk
• Mechanism: Altered atrial electrophysiology

Chronic Pain Disorders

Common SCN10A variants influence pain susceptibility:

| Condition | SCN10A Association | Effect Size |
|-----------|-------------------|-------------|
| Chronic Pain | Risk variants | Moderate |
| Post-surgical Pain | Increased intensity | Small-Medium |
| Fibromyalgia | Nominal association | Small |
| Migraine | Possible association | Limited |

Neuropathic Pain Conditions

• Diabetic Neuropathy: SCN10A variants modify risk and severity
• Chemotherapy-induced Neuropathy: Altered susceptibility
• Post-herpetic Neuralgia: Possible role in severity

Therapeutic Targeting

Drug Development Landscape

Nav1.8 is a prime target for pain therapeutics, but drug development has faced challenges[@mcgowan2022]:

Small Molecule Inhibitors

| Drug | Company | Status | Challenge |
|------|---------|--------|-----------|
| A-803467 | Pfizer | Preclinical | Limited selectivity |
| VX-150 | Vertex | Phase II | Failed - side effects |
| PF-04531083 | Pfizer | Phase II | Terminated |
| RN-1734 | Ricerca | Preclinical | Bioavailability |

Clinical Trial Failures and Lessons

• CNS Side Effects: Early Nav1.8 blockers caused CNS adverse effects
• Peripheral Selectivity: Newer compounds aim for peripheral-only inhibition
• Species Differences: Rodent vs. human channel differences complicate translation

Novel Therapeutic Approaches

Peptide Toxins

• Protoxin II (μ-TRTX Tx3-3): From tarantula venom, highly selective
• Clinical Trial: Phase I completed
• Advantage: High selectivity, no CNS penetration

Antisense Oligonucleotides

• ASO Strategy: Knock down SCN10A expression
• Advantages: Long duration, target specificity
• Challenges: Delivery, cost

Gene Therapy

• AAV-Mediated: Targeted delivery to DRG neurons
• CRISPR: Potential for precision editing
• siRNA: Short-term knockdown

Clinical Considerations

Research Directions and Knowledge Gaps

Outstanding Questions

Emerging Research Areas

• Cryo-EM Structures: High-resolution structures of Nav1.8
• Single-Cell Transcriptomics: DRG neuron subtypes expressing SCN10A
• iPSC Models: Patient-derived neurons for disease modeling
• Functional Genomics: CRISPR screens for modifiers

Cross-References and Related Entities

Related Genes and Proteins

• [SCN9A](/genes/scn9a) - Nav1.7, pain channel
• [SCN11A](/genes/scn11a) - Nav1.9, pain channel
• [SCN5A](/genes/scn5a) - Cardiac sodium channel
• [SCN1B](/genes/scn1b) - Beta subunit

Pathways

• [Pain Signaling](/mechanisms/pain-signaling)
• [Sodium Channel Biology](/mechanisms/sodium-channel-biology)
• [Ion Channels](/mechanisms/ion-channels)
• [Nociception](/mechanisms/nociception)

Diseases

• [Small Fiber Neuropathy](/diseases/small-fiber-neuropathy)
• [Brugada Syndrome](/diseases/brugada-syndrome)
• [Chronic Pain](/diseases/chronic-pain)
• [Peripheral Neuropathy](/diseases/peripheral-neuropathy)
• [Cardiac Arrhythmia](/diseases/cardiac-arrhythmia)

Key Publications

External Resources

• [NCBI Gene: SCN10A](https://www.ncbi.nlm.nih.gov/gene/6336)
• [UniProt: Nav1.8 (Q9Y5Y9)](https://www.uniprot.org/uniprotkb/Q9Y5Y9/)
• [GeneCards: SCN10A](https://www.genecards.org/cgi-bin/carddisp.pl?gene=SCN10A)
• [OMIM: 613217](https://www.omim.org/entry/613217)
• [Human Protein Atlas: SCN10A](https://www.proteinatlas.org/ENSG00000185313-SCN10A)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving SCN10A Gene discovered through SciDEX knowledge graph analysis: